Is the somatotropic axis related to sympathetic nerve activity in healthy ageing men?

Journal of Hypertension

Volumn 19, Issue 11, 2001, Pages 2019-2024

  Sverrisdottir Y B ^a   Johannsson, Gudmundur ^a   Jungersten, Lennart ^a   Wallin, B Gunnar ^a   Elam, Mikael ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ageing; Blood pressure; Insulin like growth factor I; Sympathetic nerve activity

Indexed keywords

SOMATOMEDIN C;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL INNERVATION; CARDIOVASCULAR FUNCTION; HUMAN; HYPERTENSION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SYMPATHETIC NERVE;

EID: 0034760399     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200111000-00012     Document Type: Article

References (52)

1. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age
2. Essential hypertension: A disorder of growth with origins in childhood?
3. Time-course study of blood pressure over a 20-year period in congenital blindness
4. Age-related increase in muscle sympathetic nerve activity is associated with abdominal adiposity
5. Age changes in body composition revealed by computed tomography
6. The relation of adiposity to blood pressure and development of hypertension. The Framingham study
7. Visceral obesity: A 'civilization' syndrome
8. Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia
9. Control of the forearm microcirculation: Interactions with measures of obesity and noradrenaline kinetics
10. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain
11. Body fat and sympathetic nerve activity in healthy subjects
12. Sympathetic activation in obese normotensive subjects
13. Sympathetic nervous system activity, body fatness, and body fat distribution in younger and older males
14. Low concentrations of insulin-like growth factor-I in abdominal obesity
15. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults
16. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I
17. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: Relation to cardiovascular risk factors and disease
18. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men
19. Impaired growth hormone secretion in the adult population: Relation to age and adiposity
20. The endocrinology of aging
21. Cardiovascular risk factors in adult patients with growth hormone deficiency
22. Premature mortality due to cardiovascular diseases in hypopituitarism
23. Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency
24. Plasma nitrate as an index of nitric oxide formation in man: Analyses of kinetics and confounding factors
25. Cigarette smoking increases sympathetic outflow in humans
26. Exercise increases systemic nitric oxide production in men
27. Both physical fitness and acute exercise regulate nitric oxide formation in healthy humans
28. Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man
29. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans
30. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans
31. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves
32. Microneurography and autonomic dysfunction. Low PA
33. Cardiovascular risk factors in adults with growth hormone deficiency
34. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study
35. Somatomedin-C levels in healthy young and old men: Relationship to peak and 24-hour integrated levels of growth hormone
36. Sympathetic nerve traffic correlates with the release of nitric oxide in humans: Implications for blood pressure control
37. Increased vasomotor sympathetic nerve activity and decreased plasma nitric oxide release after head-down bed rest in humans: Disappearance of correlation between vasoconstrictor and vasodilator
38. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells
39. Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production
40. Effect of energy-restricted diet on sympathetic muscle nerve activity in obese women
41. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans
42. Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension
43. Cerebral noradrenaline spillover and its relation to muscle sympathetic nervous activity in healthy human subjects
44. Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin
45. A quantitative study of muscle nerve sympathetic activity in resting normotensive and hypertensive subjects
46. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings
47. Sympathetic nerve activity and insulin in obese normotensive and hypertensive men
48. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism
49. Sympathetic overactivity in patients with chronic renal failure
50. Increased sympathetic nerve activity in renovascular hypertension
51. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension
52. Is the somatotropic axis involved in the regulation of central sympathetic outflow?